Company attributes
Industry
Location
B2X
Number of Employees (Ranges)
11 – 500
Founded Date
2016
0Other attributes
Company Operating Status
Active
Invested in
The Parker institute funds clinical trials for cancer treatments -- including for melanoma and pancreatic cancer -- and partners with cancer research centers, drug manufacturers and biotech companies to advance immunotherapy research. The institute was formed in 2016 with $250 million from the Parker Foundation.
Partners
- Amgen
- Apexigen
- BD Biosciences
- Breast Cancer Research Foundation
- Bristol-Myers Squibb
- Cancer Research Institute
- Celldex Therapeutics
- Clinakos
- Curesearch for Children's Cancer
- Emulate
- Epinomics
- Fluidigm
- ImaginAb
- Inovio Pharmaceuticals
- Seres Therapeutics
- Tempus
- Tessa Therapeutics
- Tmunity Therapeutics
Timeline
No Timeline data yet.
